Please assess the completion status of the following clinical trial:

Trial Title: A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-65~* 3-8 Migraine headaches/month~* Able to understand and comply with the study~Exclusion Criteria:~* Currently on migraine prophylaxis~* Currently on sleep medication \> 4days/month~* Currently on Fluvoxamine~* Untreated psychiatric or sleep disorders~* MRI abnormalities other than those attributable to migraine headaches~* Abnormalities on neurological exam other than known neurological disorders unassociated with migraine or sleep~* Known disorders of prolactin~* Bipolar disorder~* Hepatic disease~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): ramelteon 8 mg po qhs with sleep and migraine journal
- 2 (Type: PLACEBO_COMPARATOR): Placebo po qhs with sleep and migraine journal

Based on this trial design, predict the completion outcome and termination type (if applicable).